Telaprevir Is Effective Given Every 8 or 12 Hours With Ribavirin and Peginterferon Alfa-2a or -2b to Patients With Chronic Hepatitis C-Reference-Cited by-同舟云学术

Telaprevir Is Effective Given Every 8 or 12 Hours With Ribavirin and Peginterferon Alfa-2a or -2b to Patients With Chronic Hepatitis C

Published:2011-02 Issue:2 Volume:140 Page:459-468.e1
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Marcellin Patrick,Forns Xavier,Goeser Tobias,Ferenci Peter,Nevens Frederik,Carosi Giampiero,Drenth Joost P.,Serfaty Lawrence,De Backer Koen,Van Heeswijk Rolf,Luo Donghan,Picchio Gaston,Beumont Maria

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference26 articles.

1. Hepatitis C;Wkly Epidemiol Rec,1997

2. Hepatitis C virus infection;Lauer;N Engl J Med,2001

3. Epidemiology of hepatitis C;Alter;Hepatology,1997

4. Global epidemiology of hepatitis C virus infection;Shepard;Lancet Infect Dis,2005

5. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferon-alpha therapy;Marcellin;Ann Intern Med,1997

Cited by 121 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preferred Therapy for Specific Viral Pathogens;2024 Nelson’s Pediatric Antimicrobial Therapy;2024-02-12

2. Preferred Therapy for Specific Viral Pathogens;2023 Nelson’s Pediatric Antimicrobial Therapy;2023-03-01

3. Viral proteases as therapeutic targets;Molecular Aspects of Medicine;2022-12

4. Pharmacokinetics and Pharmacodynamics of Antiviral Drugs in Special Population;Principles and Practice of Transplant Infectious Diseases;2019

5. Twice-Daily Telaprevir for Posttransplant Genotype 1 Hepatitis C Virus: A Prospective Safety, Efficacy, and Pharmacokinetics Study;Experimental and Clinical Transplantation;2018-04